Table 2.

Patient and disease characteristics at diagnosis of BT

VariableMedian (range) or No. (%)
Patient, age, y 39.1  (11.3-73.4) 
Duration of disease, mo 24  (0-253)  
Hemoglobin level, g/dL 10.3  (5.3-15.2)  
WBC count, × 109/L 33.7  (1.5-800)  
Platelet count, × 109/L 118  (7-1623)  
PB blasts % 38  (2-100)  
PB basophils % 1  (0-34)  
BM blasts % 47  (3-100)  
Splenomegaly, %  
 No 21  (42)  
 Yes 29  (58)  
BM fibrosis grade, %  
 0 4  (10)  
 1 5  (12)  
 2 6  (15)  
 3 10  (24)  
 4 16  (39) 
No. of symptoms,* 
 0 8  (16) 
 1 11  (22)  
 2 11  (22)  
 More than 2 21  (41) 
VariableMedian (range) or No. (%)
Patient, age, y 39.1  (11.3-73.4) 
Duration of disease, mo 24  (0-253)  
Hemoglobin level, g/dL 10.3  (5.3-15.2)  
WBC count, × 109/L 33.7  (1.5-800)  
Platelet count, × 109/L 118  (7-1623)  
PB blasts % 38  (2-100)  
PB basophils % 1  (0-34)  
BM blasts % 47  (3-100)  
Splenomegaly, %  
 No 21  (42)  
 Yes 29  (58)  
BM fibrosis grade, %  
 0 4  (10)  
 1 5  (12)  
 2 6  (15)  
 3 10  (24)  
 4 16  (39) 
No. of symptoms,* 
 0 8  (16) 
 1 11  (22)  
 2 11  (22)  
 More than 2 21  (41) 
*

Fever, night sweats, weight loss, malaise, bleeding, bone pain, abdominal discomfort, focal swellings.

Close Modal

or Create an Account

Close Modal
Close Modal